Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C6H12O5 |
| Molecular Weight | 164.1567 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O
InChI
InChIKey=PNNNRSAQSRJVSB-JGWLITMVSA-N
InChI=1S/C6H12O5/c1-3(8)5(10)6(11)4(9)2-7/h2-6,8-11H,1H3/t3-,4+,5-,6-/m1/s1
| Molecular Formula | C6H12O5 |
| Molecular Weight | 164.1567 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture. | 2010-12 |
|
| The ascorbic acid content of tomato fruits is associated with the expression of genes involved in pectin degradation. | 2010-08-06 |
|
| Functional differentiation of the glycosyltransferases that contribute to the chemical diversity of bioactive flavonol glycosides in grapevines (Vitis vinifera). | 2010-08 |
|
| Application of quantitative structure-toxicity relationships for acute NSAID cytotoxicity in rat hepatocytes. | 2005-02-10 |
|
| Synthesis and amphiphilic properties of glycosyl-1,4-benzodiazepin-2,5-diones. | 2000-10-20 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:19:46 GMT 2025
by
admin
on
Mon Mar 31 19:19:46 GMT 2025
|
| Record UNII |
O654621E3T
|
| Record Status |
FAILED
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
O654621E3T
Created by
admin on Mon Mar 31 19:19:46 GMT 2025 , Edited by admin on Mon Mar 31 19:19:46 GMT 2025
|
PRIMARY | |||
|
42606
Created by
admin on Mon Mar 31 19:19:46 GMT 2025 , Edited by admin on Mon Mar 31 19:19:46 GMT 2025
|
PRIMARY | |||
|
488-79-9
Created by
admin on Mon Mar 31 19:19:46 GMT 2025 , Edited by admin on Mon Mar 31 19:19:46 GMT 2025
|
ALTERNATIVE | |||
|
7658-08-4
Created by
admin on Mon Mar 31 19:19:46 GMT 2025 , Edited by admin on Mon Mar 31 19:19:46 GMT 2025
|
PRIMARY | |||
|
231-622-2
Created by
admin on Mon Mar 31 19:19:46 GMT 2025 , Edited by admin on Mon Mar 31 19:19:46 GMT 2025
|
PRIMARY | |||
|
28140
Created by
admin on Mon Mar 31 19:19:46 GMT 2025 , Edited by admin on Mon Mar 31 19:19:46 GMT 2025
|
PRIMARY | |||
|
DTXSID701032788
Created by
admin on Mon Mar 31 19:19:46 GMT 2025 , Edited by admin on Mon Mar 31 19:19:46 GMT 2025
|
PRIMARY | |||
|
93579
Created by
admin on Mon Mar 31 19:19:46 GMT 2025 , Edited by admin on Mon Mar 31 19:19:46 GMT 2025
|
PRIMARY | |||
|
33980
Created by
admin on Mon Mar 31 19:19:46 GMT 2025 , Edited by admin on Mon Mar 31 19:19:46 GMT 2025
|
PRIMARY | |||
|
m9464
Created by
admin on Mon Mar 31 19:19:46 GMT 2025 , Edited by admin on Mon Mar 31 19:19:46 GMT 2025
|
PRIMARY | Merck Index |